Keyphrases
Metabolic Phenotype
100%
Mammalian Target of Rapamycin (mTOR)
100%
Peroxisome Proliferator-activated Receptor
100%
Estrogen Receptor-positive
100%
Mammary Neoplasia
100%
Inflammatory Phenotype
100%
Tumorigenesis
40%
Histopathological Changes
40%
GW501516
40%
Inflammation
20%
Therapeutic Approaches
20%
Transgenic Mouse Model
20%
Everolimus
20%
Lipid Metabolism
20%
Metabolic
20%
Estrogen Receptor
20%
Progesterone Receptor
20%
ErbB2
20%
Mammary Tumorigenesis
20%
Ligand-receptor Binding
20%
MTOR Inhibitor
20%
Glucose Metabolism
20%
Physiological Processes
20%
Mammary Gland
20%
Latency
20%
Potential Risk Factors
20%
Synthetic Ligands
20%
Phosphatidylcholine
20%
Mammary Epithelium
20%
Mammary Carcinoma
20%
Endogenous Ligand
20%
Trophoblast
20%
Acid Metabolite
20%
Lysophosphatidic Acid
20%
Peroxisome Proliferator-activated Receptor Agonists
20%
Tumor Latency
20%
Infiltrating Ductal Carcinoma
20%
Malignant Change
20%
PLAC1
20%
Gene Signature
20%
Medicine and Dentistry
Neoplasm
100%
Peroxisome Proliferator Activated Receptor
100%
Mammalian Target of Rapamycin
100%
Estrogen Receptor
100%
Carcinogenesis
60%
[2 Methyl 4 [4 Methyl 2 (4 Trifluoromethylphenyl) 5 Thiazolylmethylthio]phenoxy]acetic Acid
40%
Transgenic Mouse
20%
mTOR Signaling
20%
Everolimus
20%
Breast Carcinoma
20%
Glucose Metabolism
20%
Mammary Epithelium
20%
Physiological Process
20%
Akt Signaling
20%
Peroxisome Proliferator Activated Receptor Agonist
20%
Ductal Carcinoma
20%
Mammalian Target of Rapamycin Inhibitor
20%
Metabolite
20%
Progesterone Receptor
20%
Lipid Metabolism
20%
Trophoblast
20%
Egg Lecithin
20%
Lysophosphatidic Acid
20%
Diseases
20%
Biochemistry, Genetics and Molecular Biology
Mammalian Target of Rapamycin
100%
Estrogen Receptor
100%
Peroxisome Proliferator-Activated Receptor
100%
Carcinogenesis
60%
GW501516
40%
Mouse Model
20%
Trophoblast
20%
Metabolite
20%
Lipid Metabolism
20%
Gene Signature
20%
mTOR Signaling
20%
Glucose Metabolism
20%
Transgenic Mouse
20%
Physiological Process
20%
Akt Signaling
20%
Progesterone Receptor
20%
PPAR Agonist
20%
Lecithin
20%
Lysophosphatidic Acid
20%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Peroxisome Proliferator Activated Receptor
100%
Neoplasm
100%
Carcinogenesis
60%
GW501516
40%
Transgenic Mouse
20%
Mouse Model
20%
Egg Lecithin
20%
Everolimus
20%
Breast Carcinoma
20%
Mammalian Target of Rapamycin Inhibitor
20%
PPAR Agonist
20%
Paget Nipple Disease
20%
Inflammation
20%
Progesterone Receptor
20%
Lysophosphatidic Acid
20%
Diseases
20%
Immunology and Microbiology
Peroxisome
100%
GW501516
33%
Everolimus
16%
Mouse Model
16%
Agonist
16%
Transgenic Mouse
16%
Physiological Process
16%
Glucose Metabolism
16%
Akt Signaling
16%
mTOR Signaling
16%
Metabolite
16%
Lipid Metabolism
16%
Trophoblast
16%
Mammary Gland
16%